Pre-Diabetes Risk Score effectively combats type 2 diabetes in Qatar
(MENAFN) A recent study has unveiled the potential of a new tool, the Pre-Diabetes Risk Score in Qatar (PRISQ), in effectively combating the prevalence of type 2 diabetes in Qatar and potentially beyond. Developed using clinical data from Qatar Biobank and relying solely on non-invasive parameters, PRISQ has demonstrated an impressive ability to diagnose pre-diabetes in over 90 percent of individuals in real clinical settings.
Published in the BMJ Public health journal, the study titled "Real-world clinical validation of the Qatar pre-diabetes risk score: a cross-sectional study" underscores PRISQ's role as a robust solution for rapid and cost-effective pre-diabetes diagnosis. By utilizing non-invasive parameters exclusively, PRISQ offers a practical approach to identifying individuals at risk of developing type 2 diabetes early on.
Pre-diabetes, characterized by elevated blood sugar levels that do not yet meet the threshold for type 2 diabetes, poses a significant health risk. Individuals with pre-diabetes are more susceptible to progressing to full-blown diabetes compared to those with normal blood sugar levels. Therefore, effective management of pre-diabetes through lifestyle modifications such as diet and exercise can substantially mitigate the risk of developing type 2 diabetes, emphasizing the critical need for early intervention strategies.
The introduction of PRISQ represents a promising advancement in diabetes prevention efforts, particularly in regions like Qatar where diabetes prevalence is a major public health concern. By enabling early identification and proactive management of pre-diabetes, PRISQ has the potential to significantly reduce the burden of type 2 diabetes and improve long-term health outcomes for individuals at risk.
MENAFN03072024000045015839ID1108402428
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.